VitaDAO Closes $4.1M Funding Round With Pfizer Ventures for Longevity Research

0
12



VitaDAO was started in 2021 by Tyler Golato of decentralized biotech protocol Molecule to fund longevity research. According to the organization, it boasts a community of over 9,000 “enthusiasts, researchers and contributors,” and deployed over $3.5 million to projects researching diseases of aging, cellular biology and repairing age-related damage to the body in 2022.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here